D-1074-2019 Class II Terminated

Recalled by Jubilant Cadista Pharmaceuticals, Inc. — Salisbury, MD

FDA drug recall D-1074-2019 was initiated by Jubilant Cadista Pharmaceuticals, Inc. on Mar 29, 2019 and is designated Class II. Reason for recall: Discoloration: Expansion of an earlier recall due to the presence of dark brown discoloration on the edges of the tablets. The recall status is terminated (terminated Sep 20, 2019). Affected quantity: 12,960 bottles.

Recall details

Product Type
Drugs
Report Date
Apr 10, 2019
Initiation Date
Mar 29, 2019
Termination Date
Sep 20, 2019
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
12,960 bottles

Product description

Pantoprazole Sodium Delayed-Release Tablets, USP, 40 mg*, 90-count bottle, Rx Only, Manufactured by: Jubilant Generics Ltd., Roorkee - 247661, India; Marketed by: Jubilant Cadista Pharmaceuticals Inc., Salisbury, MD 21801; NDC 59746-284-90.

Reason for recall

Discoloration: Expansion of an earlier recall due to the presence of dark brown discoloration on the edges of the tablets.

Distribution pattern

Nationwide in the USA.

Code information

Lot #: PA217060A, Exp 05/2020

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-1074-2019
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-1074-2019. Report a data issue: hello@regdatalab.com.